Bioresorbable coronary scaffolds: a novel device-based solution in search of its clinical need.
نویسندگان
چکیده
This editorial refers to ‘Bioresorbable scaffolds: rationale, current status, challenges, and future’, by J. Iqbal et al., on page 765, ‘Bioresorbable vascular scaffolds in acute STsegment elevation myocardial infarction: a prospective multicentre study ‘PRAGUE 19’’, by V Kočka et al., on page 787, and ‘Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with STsegment elevation myocardial infarction. BVS STEMI FIRST Study’, by R. Diletti et al., on page 777
منابع مشابه
Bioresorbable vascular scaffold: promises and the fallen child-as-king?
Correspondence to Stéphane Cook; [email protected] THE BIORESORBABLE VASCULAR SCAFFOLDS ‘BVS’ The main limitation of percutaneous coronary intervention compared to open-heart surgery is the insertion of a foreign body (usually a stent) inside the coronary artery. This is associated with foreign body inflammation that triggers restenosis, neoatherosclerosis and late-occurring stent thrombos...
متن کاملBioresorbable Scaffolds: The Revolution in Coronary Stenting?
Bioresorbable scaffolds (BRS) represent the latest revolution in interventional cardiology. Thanks to their reabsorptive properties, they provide temporary scaffolding that helps stabilizing the plaque and promotes healing, and then disappear, thus restoring a functional endothelium and vasomotion. Several devices have been tested at the preclinical and clinical stage. Here we review the ration...
متن کاملBioresorbable Drug-Eluting Magnesium-Alloy Scaffold for Treatment of Coronary Artery Disease
The introduction of metallic drug-eluting stents has reduced the risk of restenosis and widened the indications of percutaneous coronary intervention in treatment of coronary artery disease. However, this medical device can induce hypersensitive reaction that interferes with the endothelialization and healing process resulting in late persistent or acquired malapposition of the permanent metall...
متن کاملBioresorbable Scaffold: The Emerging Reality and Future Directions.
In the era of drug-eluting stents, large-scale randomized trials and all-comer registries have shown excellent clinical results. However, even the latest-generation drug-eluting stent has not managed to address all the limitations of permanent metallic coronary stents, such as the risks of target lesion revascularization, neoatherosclerosis, preclusion of late lumen enlargement, and the lack of...
متن کاملBioresorbable Scaffolds: Current Evidence and Ongoing Clinical Trials
Bioresorbable scaffolds (BRS) represent a novel approach in coronary stent technology. In contrast to the metallic stents, they provide transient scaffolding, thereby safeguarding early vessel patency and acute gain. Subsequently a process of "decomposition" occurs, that results in the complete absorption of the scaffold. This reduces the risk of late complications, allowing the vessel to maint...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- European heart journal
دوره 35 12 شماره
صفحات -
تاریخ انتشار 2014